secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2022-07-27T23:59:59+00:00
Accession:  0001213900-22-041877
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve extension of business combination deadline to Nov 2022
---------------------------------------------------------------------------

- Extension Proposal approved: 15,084,246 for, 1,365,812 against, 0 abstain.
- Deadline extended from Aug 6, 2022 to Nov 6, 2022, with option for monthly extensions to Feb 6, 2023.
- Proxies received for 80.4% of 20,450,000 outstanding shares, quorum present.
- Adjournment Proposal not needed due to sufficient votes for Extension Proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000121390022041877/0001213900-22-041877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000121390022041877/ea163407-8k_healthsci2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-041877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer